Emmaus Life Sciences Receives Marketing Authorization for Endari® in Oman

Sickle Cell Disease Treatment Commercially Available in Five GCC Countries
TORRANCE, Calif., July 13, 2023 /PRNewswire/ -- Emmaus Life Sciences, Inc. , a leader in sickle cell disease treatment,...

Related Keywords

Woman ,Kuwait ,Israel ,United Arab Emirates ,Saudi Arabia ,Bahrain ,Qatar ,Netherlands ,United States ,France ,Omanis ,Kingdom Of Saudi Arabia ,Omani ,Americans ,George Sekulich ,Yutaka Niihara ,Willis Lee ,Emmaus Life Sciences ,Exchange Commission ,Prnewswire Emmaus Life Sciences Inc ,Blueprint For Action National Academy Of Sciences ,Centers For Disease ,Oman Ministry Of Health ,National Center On Birth Defects ,Global Commercialization Of Emmaus Life Sciences Inc ,Company Contact ,Committee On Addressing Sickle Cell Disease ,Emmaus Life Sciences Inc ,Life Sciences ,Oman Ministry ,Chief Executive Officer ,Senior Vice President ,Global Commercialization ,Prescribing Information ,Sickle Cell Disease ,National Center ,Birth Defects ,Developmental Disabilities ,Disease Control ,Addressing Sickle Cell Disease ,Strategic Plan ,Sciences Press ,Private Securities Litigation Reform Act ,